Recombinant antibody having unique glycan profile produced by CHO host cell with edited… Grant US-11505609-B2 United States of America 22 Nov 2022
Human monoclonal antibody targeting TNFR2 for cancer immunotherapy Grant US-11389480-B2 United States of America 19 Jul 2022
Methods and compositions for making antibodies and antibody derivatives with reduced core… Grant US-11319526-B2 United States of America 03 May 2022
Buffer formulations for enhanced antibody stability Grant US-11285210-B2 United States of America 29 Mar 2022
DNA antibody constructs and method of using same Grant US-11208470-B2 United States of America 28 Dec 2021
Dosage and administration of non-fucosylated anti-CD40 antibodies Grant AU-2015339128-C1 Australia 16 Dec 2021
RECOMBINANT ANTIBODY HAVING UNIQUE GLYCAN PROFILE PRODUCED BY CHO HOST CELL WITH EDITED… Application EP-3666891-A4 European Patent Office 18 Aug 2021
Methods of inhibition of protein fucosylation in vivo using fucose analogs Grant US-11033561-B2 United States of America 15 Jun 2021
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES Application EP-3831847-A1 European Patent Office 09 Jun 2021
Bispecific antibodies and methods for production thereof Grant US-10906991-B2 United States of America 02 Feb 2021
Dosage and administration of non-fucosylated anti-CD40 antibodies Grant AU-2015339128-B2 Australia 21 Jan 2021
Modulation of charge variants in a monoclonal antibody composition Grant US-10696735-B2 United States of America 30 Jun 2020
Methods and compositions for making antibodies and antibody derivatives with reduced core… Grant US-10443035-B2 United States of America 15 Oct 2019
Buffer formulations for enhanced antibody stability Application US-10376582-B2 United States of America 13 Aug 2019
Treatment of sickle cell disease and inflammatory conditions Grant US-10350228-B2 United States of America 16 Jul 2019
Methods of inhibition of protein fucosylation in vivo using fucose analogs Grant US-10342811-B2 United States of America 09 Jul 2019
Geminiviral vector for expression of rituximab Grant US-10125373-B2 United States of America 13 Nov 2018
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES Application EP-3212230-A4 European Patent Office 20 Jun 2018
Use of ADCC-optimized antibodies for treating low-responder patients Grant US-9879089-B2 United States of America 30 Jan 2018
Methods and compositions for making antibodies and antibody derivatives with reduced core… Grant US-9816069-B2 United States of America 14 Nov 2017
Glycosylation engineering of antibodies for improving antibody-dependent cellular… Grant US-9718885-B2 United States of America 01 Aug 2017
MODULATION OF AFUCOSYLATED SPECIES IN A MONOCLONAL ANTIBODY COMPOSITION Application WO-2017120347-A1 World Intellectual Property Organisation (WIPO) 13 Jul 2017
VERTEBRATE OR INSECT CELL FOR PRODUCING A PROTEIN OR LIPID LACKING FUCOSE OR HAVING A… Application EA-026336-B1 Eurasian Patent Organisation 31 Mar 2017
Methods of inhibition of protein fucosylation in vivo using fucose analogs Grant US-9504702-B2 United States of America 29 Nov 2016
COMBINATION THERAPY WITH NON-FUCOSYLATED ANTI-CD20 ANTIBODY AND BENDAMUSTINE Application RU-2575820-C2 Russian Federation 20 Feb 2016
Bispecific antibodies and methods for production thereof Grant US-9212230-B2 United States of America 15 Dec 2015
Glycosylation engineering of antibodies for improving antibody-dependent cellular… Grant US-9139654-B2 United States of America 22 Sep 2015
Use of ADCC-optimized antibodies for treating weak patients Grant US-9109020-B2 United States of America 18 Aug 2015
Glycosylation engineering of antibodies for improving antibody-dependent cellular… Grant US-9068005-B2 United States of America 30 Jun 2015
Methods and compositions for making antibodies and antibody derivatives with reduced core… Grant US-8993326-B2 United States of America 31 Mar 2015
Process for producing molecules containing specialized glycan structures Grant US-8642292-B2 United States of America 04 Feb 2014
Methods and compositions for making antibodies and antibody derivatives with reduced core… Grant US-8574907-B2 United States of America 05 Nov 2013
Use of ADCC-optimized antibodies for treating weak patients Grant US-8501171-B2 United States of America 06 Aug 2013
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MDM2 INHIBITOR Application WO-2012080389-A1 World Intellectual Property Organisation (WIPO) 21 Jun 2012
Method for treating infectious disease using monoclonal antibodies Grant US-8178093-B2 United States of America 15 May 2012
Methods and compositions for making antibodies and antibody derivatives with reduced core… Grant US-8163551-B2 United States of America 24 Apr 2012
Method for treating cancer using monoclonal antibodies Grant US-8153124-B2 United States of America 10 Apr 2012
PRODUCTION OF LOW FUCOSE ANTIBODIES IN H4-II-E RAT CELLS Application WO-2012041768-A1 World Intellectual Property Organisation (WIPO) 05 Apr 2012
Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies Grant US-8124078-B2 United States of America 28 Feb 2012
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH AN ANTI-VEGF ANTIBODY Application WO-2012022747-A1 World Intellectual Property Organisation (WIPO) 23 Feb 2012
Virally-safe factor VIII with a low content of higher multimers Grant US-7932355-B2 United States of America 26 Apr 2011
PROCESS FOR PRODUCING MOLECULES CONTAINING SPECIALIZED GLYCAN STRUCTURES Application WO-2011035884-A1 World Intellectual Property Organisation (WIPO) 31 Mar 2011
Use of ADCC-optimized antibodies for treating low-responder patients Grant US-7713524-B2 United States of America 11 May 2010
SUGAR CHAIN-MODIFIED ANTI-HM1.24 ANTIBODY Application EP-1666501-A4 European Patent Office 24 Dec 2008
SUGAR CHAIN-MODIFIED ANTI-HM1.24 ANTIBODY Application EP-1666501-A1 European Patent Office 07 Jun 2006